Validation of the French ATI Scale and Predisposition to Use Technological Tools in Rehabilitation.
Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Apr 9, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a questionnaire called the Affinity for Technology Interaction (ATI) to see how well it helps identify people who are comfortable using technology during their rehabilitation after a stroke. The questionnaire, which has been translated into French, has nine questions that measure how likely someone is to use technological tools. By understanding how patients feel about using technology, healthcare providers can better direct them to tele-rehabilitation options, which are treatments that can be done at home using technology, in addition to traditional therapy.
To participate in this study, you need to be an adult (over 18 years old), speak and understand French, and have had one stroke at least a month ago. You should also be able to give consent to join the study. Participants will complete the questionnaire, and researchers will gather information about how ready people are to use technology for their rehabilitation, including any challenges they face. This trial is currently recruiting new participants and aims to help improve rehabilitation options for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult subjects (\> 18 years)
- • Speak and understand French;
- • Be able to give consent in paper or electronic format.
- • Have had a single stroke;
- • Have been out of hospital for at least 1 month.
- Exclusion Criteria:
- • Severe comprehension problems ;
- • Inability to complete the questionnaire;
- • Severe comprehension problems, prior to or following the stroke, preventing planned assessments.
About Cliniques Universitaires Saint Luc Université Catholique De Louvain
Cliniques Universitaires Saint-Luc, affiliated with the Université Catholique de Louvain, is a leading academic medical center in Belgium dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, it focuses on a wide range of therapeutic areas, prioritizing patient safety and ethical standards. The institution is committed to fostering collaboration between researchers and clinicians to enhance medical knowledge and improve treatment outcomes, contributing significantly to the global scientific community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussel, Woluwé Saint Lambert, Belgium
Brussel, , Belgium
Patients applied
Trial Officials
Lejeune Thierry
Principal Investigator
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported